PMID: 7932806Oct 19, 1994Paper

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

Journal of the National Cancer Institute
T C ChouG J Bosl

Abstract

Cisplatin-based induction chemotherapy may achieve a complete response (i.e., no sign of tumor following treatment) in 70%-80% of patients with germ cell tumors. However, only a minority of patients in whom the firstline regimens fail are cured with the salvage regimens. The aim of these studies was to identify new agents or new regimens for the treatment of germ cell tumors by carrying out quantitative assessment in vitro of two promising new antitumor agents (paclitaxel [Taxol] and topotecan) and three more established agents (cisplatin, vincristine, and etoposide). These agents were used singly or in two- and three-drug combinations and were selected because they represent five distinct categories of antineoplastic mechanisms. The combination index-isobologram method, which is based on the median-effect principle developed by Chou and Talalay, was used for computerized data analysis. This method was selected because it takes into account both the potencies of each drug and combinations of these drugs and the shapes of their dose-effect curves. Synergism against the growth of teratocarcinoma cells resistant to cisplatin (833K/64CP10 cells) was greater than against the growth of parent 833K cells. The degrees of synergism were...Continue Reading

Citations

Jan 1, 1995·Investigational New Drugs·H S PucR J Motzer
Feb 26, 2005·Cancer Chemotherapy and Pharmacology·Risa TanakaShuji Nakano
May 6, 2005·Cancer Chemotherapy and Pharmacology·Risa TanakaShuji Nakano
Sep 28, 2007·Cancer Chemotherapy and Pharmacology·Wei WangJiang Zheng
Oct 9, 2007·Cancer Chemotherapy and Pharmacology·Dominique KoensgenUNKNOWN North-Eastern German Society of Gynecological Oncology Study Group-Ovarian Cancer
Nov 18, 2010·Archives of Gynecology and Obstetrics·Ansgar Brüning, Ioannis Mylonas
Feb 28, 2006·Breast Cancer Research and Treatment·Mark N KirsteinDouglas Yee
Aug 14, 2012·Journal of Natural Medicines·Shuai HuangJie Weng
Nov 30, 2012·Journal of Natural Medicines·Shuai HuangJie Weng
Oct 21, 2010·Virologica Sinica·Dao-min Zhuang, Jing-yun Li
May 31, 2012·Archives of Pharmacal Research·Su-Jin KangBong-Jin Lee
Mar 17, 2004·Biochemical and Biophysical Research Communications·Tieran HanRam P Agarwal
Mar 19, 2008·Biochemical Pharmacology·Malgorzata CzyzMalgorzata Sztiller-Sikorska
Aug 21, 2003·Gynecologic Oncology·Larry J CopelandUNKNOWN Gynecologic Oncology Group Protocol GOG 182-ICON5
Sep 18, 2003·Gynecologic Oncology·James V Fiorica
Dec 18, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S TumoloM G Boccieri
Jul 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A FontA Abad
Jun 5, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Caio M Rocha Lima, Alberto Chiappori
Dec 10, 2002·Cancer Treatment Reviews·M CrulJ H M Schellens
Jun 5, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D PectasidesA Athanassiou
Sep 3, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Gross-GoupilF Goldwasser
Feb 13, 2001·Critical Reviews in Oncology/hematology·W ZoliD Amadori
Aug 2, 2002·Breast Cancer Research and Treatment·Daniel R Budman, Anthony Calabro
Aug 22, 2006·Nature Chemical Biology·Jonathan B FitzgeraldPeter K Sorger
Nov 7, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Séverine WackAmor Hajri
Mar 16, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·Ting-Chao Chou
Jun 5, 2003·Seminars in Hematology·Alex J Tipping, Junia V Melo
May 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P A ZucaliG Giaccone
Jul 22, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Esparís-OgandoA Pandiella
Jan 14, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P C EnzingerC S Fuchs
Aug 11, 2012·Briefings in Bioinformatics·Elaine L LeungLiang Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
U VanhoeferS Seeber
© 2021 Meta ULC. All rights reserved